Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions

Health professionals working in CVD care should be aware of the need to investigate patients with coronary disease for Lp(a) and be equipped to give advice on how to reduce overall cardiovascular risk especially given the absence of licenced therapies to treat Lp(a).

Authors

Institutions

Publication Details

Journal
European Journal of Cardiovascular Nursing
Published
2025-08-29
DOI
https://doi.org/10.1093/eurjcn/zvaf174
Citations
3
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
6.02
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions

Elijah Nyainda Ogola, Lilian Kagure Mbau, Kausik Kumar Ray, Kornelia Kotseva et al.
3 citations
European Journal of Cardiovascular Nursing
Lipoproteins and Cardiovascular Health
6.02
article

Patient perceptions on lipoprotein(a) testing and treatment for secondary prevention of cardiovascular disease: results from the INTERASPIRE study in seven countries across five World Health Organization regions

Elijah Nyainda Ogola, Lilian Kagure Mbau, Kausik Kumar Ray, Kornelia Kotseva, Jaimini Cegla, Sandra Ganly, John-Paul Corry, Diana Hui Ping Foo, Chris Noone, Mahmoud Umar Sani, Dirk De Bacquer, Okechukwu S. Ogah, Piotr Jankowski, Adalberto Quintero-Baiz, Amam Mbakwem, Agnieszka Adamska, Wael Almahmeed, Eanna Kenny, Ahmad Syadi Mahmood Zuhdi, Paula Luna Bonilla, Yong Huo, John W. McEvoy, Miguel Urina‐Triana, Renata Wolfshaut–Wolak, Rose Hui-Chin Jong, Yongbo Li, Junbo Ge, Catriona Jennings, Nooshin Bazargani, Nancy Xinrong Ji, D.R. Wood, Juwairia Alali
article en
3 citations

Abstract

Health professionals working in CVD care should be aware of the need to investigate patients with coronary disease for Lp(a) and be equipped to give advice on how to reduce overall cardiovascular risk especially given the absence of licenced therapies to treat Lp(a).

European Journal of Cardiovascular Nursing
Jagiellonian University (PL), University of Nairobi (KE), University Malaya Medical Centre (MY), Imperial College Healthcare NHS Trust (GB), Ollscoil na Gaillimhe – University of Galway (IE), University of Lagos (NG), Peking University (CN), Fudan University (CN), University College Hospital, Ibadan (NG), Rashid Hospital (AE), Sarawak General Hospital (MY), Dubai Hospital (AE), Ghent University (BE), Abu Dhabi Health Services (AE), St Mary's Hospital (GB), Zhongshan Hospital (CN), Peking University First Hospital (CN), Universidad Simón Bolívar (CO), Suzhou Traditional Chinese Medicine Hospital (CN), Postgraduate School of Molecular Medicine (PL), Croí (IE), Child Welfare Society of Kenya (KE), Huashan Hospital (CN), Colombian Association of Surgery (CO), Bayero University Kano (NG)
Openalex Percentile: Top 4%
Lipoproteins and Cardiovascular Health
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.